• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种中空介孔硅纳米颗粒疫苗,以预防屋尘螨引起的过敏炎症。

Development of a hollow mesoporous silica nanoparticles vaccine to protect against house dust mite induced allergic inflammation.

机构信息

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, 100 Haining Road, Shanghai, China.

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, 100 Haining Road, Shanghai, China.

出版信息

Int J Pharm. 2018 Oct 5;549(1-2):115-123. doi: 10.1016/j.ijpharm.2018.07.047. Epub 2018 Jul 21.

DOI:10.1016/j.ijpharm.2018.07.047
PMID:30040973
Abstract

Allergen specific immunotherapy (SIT) is the only specific therapeutic way for house dust mite (HDM) allergy. To improve the efficacy of SIT, hollow mesoporous silica nanoparticles (HMSNs) were used as vehicles for HDM allergen. The HMSNs were prepared and characterized. The major HDM allergen (Der f2) was loaded onto HMSNs, and the drug loading capacity and release profile were determined. Then the Der f2 loaded HMSNs were injected subcutaneously to mouse model of Der f2 induced allergic asthma and the preventive effects were evaluated. Our results showed that HMSNs were spherical (100 nm) with pore diameter of 2.897 nm and successfully loaded with Der f2 protein. The loading capacity is 90 μg Der f2/1 mg HMSNs. The Der f2 loaded on HMSNs released slowly in 72 h. Treatment with Der f2 loaded HMSNs could efficiently decrease Der f2 specific IgE levels, inflammatory cells infiltration in lung tissue, and Th2 cytokine IL4 levels in BALF. In the meanwhile, it could increase the Der f2 specific IgG levels, Th1 cytokine IFN-γ levels, and induce proliferation of splenocytes to Der f2 accompanied by increased IFN-γ levels. These results showed that Der f2 loaded HMSNs were efficient in preventing allergic inflammation, and HMSNs may be potential vehicles for SIT of HDM allergy.

摘要

变应原特异性免疫治疗(SIT)是治疗屋尘螨(HDM)过敏的唯一特异性治疗方法。为了提高 SIT 的疗效,中空介孔硅纳米粒子(HMSNs)被用作 HDM 过敏原的载体。制备并表征了 HMSNs。将主要的 HDM 过敏原(Der f2)加载到 HMSNs 上,并确定了载药量和释放曲线。然后将负载 Der f2 的 HMSNs 注射到 Der f2 诱导的过敏性哮喘小鼠模型中,评估其预防效果。我们的结果表明,HMSNs 呈球形(100nm),孔径为 2.897nm,并成功负载了 Der f2 蛋白。载药量为 90μg Der f2/1mg HMSNs。负载在 HMSNs 上的 Der f2 在 72 小时内缓慢释放。负载 Der f2 的 HMSNs 治疗可有效降低 Der f2 特异性 IgE 水平、肺组织中炎性细胞浸润和 BALF 中的 Th2 细胞因子 IL4 水平。同时,它可以增加 Der f2 特异性 IgG 水平、Th1 细胞因子 IFN-γ 水平,并诱导脾细胞对 Der f2 的增殖,同时伴有 IFN-γ 水平的增加。这些结果表明,负载 Der f2 的 HMSNs 能有效预防过敏炎症,HMSNs 可能是 HDM 过敏 SIT 的潜在载体。

相似文献

1
Development of a hollow mesoporous silica nanoparticles vaccine to protect against house dust mite induced allergic inflammation.开发一种中空介孔硅纳米颗粒疫苗,以预防屋尘螨引起的过敏炎症。
Int J Pharm. 2018 Oct 5;549(1-2):115-123. doi: 10.1016/j.ijpharm.2018.07.047. Epub 2018 Jul 21.
2
Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics.在过敏性哮喘患者单次支气管螨变应原挑战后,过敏原特异性 IgE 和体外 Th2 反应增加。
Allergy. 2012 Jan;67(1):67-73. doi: 10.1111/j.1398-9995.2011.02722.x. Epub 2011 Sep 29.
3
CRM197-Coupled Der p 2 Peptides Suppress Allergic Airway Inflammation in a Der p 2-Induced Asthma Mouse Model.CRM197 偶联 Der p 2 肽抑制 Der p 2 诱导的哮喘小鼠模型中的过敏气道炎症。
Int Arch Allergy Immunol. 2019;180(3):173-181. doi: 10.1159/000502607. Epub 2019 Sep 19.
4
The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.白细胞介素-33受体ST2在哮喘的屋尘螨小鼠模型中,对于外周气道高反应性和炎症的发展至关重要。
Clin Exp Allergy. 2016 Mar;46(3):479-90. doi: 10.1111/cea.12683.
5
Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.将 Der p 23(一种新型主要屋尘螨过敏原)转化为低变应原疫苗。
J Immunol. 2014 May 15;192(10):4867-75. doi: 10.4049/jimmunol.1400064. Epub 2014 Apr 14.
6
House Dust Mite-Specific Sublingual Immunotherapy Prevents the Development of Allergic Inflammation in a Mouse Model of Experimental Asthma.屋尘螨特异性舌下免疫疗法可预防实验性哮喘小鼠模型中变应性炎症的发展。
Int Arch Allergy Immunol. 2016;170(1):22-34. doi: 10.1159/000446155. Epub 2016 Jun 9.
7
Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma.在屋尘螨哮喘模型中,针对白细胞介素-33进行疫苗接种可抑制气道高反应性和炎症。
PLoS One. 2015 Jul 27;10(7):e0133774. doi: 10.1371/journal.pone.0133774. eCollection 2015.
8
Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.变应性哮喘小鼠模型中的皮下和舌下免疫疗法。
Methods Mol Biol. 2017;1559:137-168. doi: 10.1007/978-1-4939-6786-5_11.
9
[Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].[标准化屋尘螨疫苗1年特异性免疫疗法对轻至中度过敏性哮喘患者的疗效]
Zhonghua Jie He He Hu Xi Za Zhi. 2006 Oct;29(10):679-87.
10
Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.用于变应原特异性免疫疗法的主要屋尘螨变应原Der p 1和Der p 2的工程改造
Clin Exp Allergy. 2009 Jul;39(7):1088-98. doi: 10.1111/j.1365-2222.2009.03264.x. Epub 2009 Apr 21.

引用本文的文献

1
Nanotechnology-driven strategies for tilapia vaccines: Comparative evaluation of nanoemulsions and silica nanoparticles against .罗非鱼疫苗的纳米技术驱动策略:纳米乳剂和二氧化硅纳米颗粒对……的比较评估
Vet World. 2025 Jul;18(7):1807-1818. doi: 10.14202/vetworld.2025.1807-1818. Epub 2025 Jul 8.
2
Development of a Ferritin-Based Nano-Allergen and Its Immunological Effects in vitro and in vivo.基于铁蛋白的纳米变应原的研制及其体内外免疫效应
Int J Nanomedicine. 2025 Jul 30;20:9505-9516. doi: 10.2147/IJN.S527210. eCollection 2025.
3
Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders.
基于介孔二氧化硅的纳米平台是用于治疗炎症性疾病的诊疗试剂。
Pharmaceutics. 2023 Jan 28;15(2):439. doi: 10.3390/pharmaceutics15020439.
4
Recent Advances in Nanomaterials for Asthma Treatment.纳米材料在哮喘治疗中的最新进展。
Int J Mol Sci. 2022 Nov 20;23(22):14427. doi: 10.3390/ijms232214427.
5
pH-Controlled Release of Antigens Using Mesoporous Silica Nanoparticles Delivery System for Developing a Fish Oral Vaccine.利用介孔硅纳米粒子递送系统控制 pH 释放抗原用于开发鱼类口服疫苗。
Front Immunol. 2021 Apr 19;12:644396. doi: 10.3389/fimmu.2021.644396. eCollection 2021.
6
Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy.免疫检查点阻断治疗的分子谱与年龄相关的差异。
Front Immunol. 2021 Apr 15;12:657575. doi: 10.3389/fimmu.2021.657575. eCollection 2021.
7
Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon.变应原免疫疗法在人类和兽医患者中的制剂:新的候选药物即将出现。
Front Immunol. 2020 Aug 4;11:1697. doi: 10.3389/fimmu.2020.01697. eCollection 2020.
8
Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease.致敏、效应功能和变应性疾病治疗中颗粒的作用机制。
Front Immunol. 2020 Jun 30;11:1334. doi: 10.3389/fimmu.2020.01334. eCollection 2020.
9
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review.用于肿瘤学中药物和核酸共递送的介孔二氧化硅纳米颗粒:综述
Pharmaceutics. 2020 Jun 8;12(6):526. doi: 10.3390/pharmaceutics12060526.
10
Co-delivery of allergen epitope fragments and R848 inhibits food allergy by inducing tolerogenic dendritic cells and regulatory T cells.过敏原表位片段和 R848 的共递送通过诱导耐受原性树突状细胞和调节性 T 细胞来抑制食物过敏。
Int J Nanomedicine. 2019 Aug 30;14:7053-7064. doi: 10.2147/IJN.S215415. eCollection 2019.